TY - JOUR
T1 - The Support of Continuing Medical Education by Pharmaceutical Companies
AU - Kaplan, Norman M
PY - 1979/1/25
Y1 - 1979/1/25
N2 - This communication is being started as I await a flight to New Orleans, where I am to give Medical Grand Rounds at the LSU Medical School later today. The expenses for my trip and an honorarium of $500 are being provided by the USV Pharmaceutical Company. These arrangements were made by the chairman of the department who wished to invite me. My talk, “Alpha- and Beta-Blockers in the Treatment of Hypertension,” will make only brief mention of diuretics and no reference to the diuretic marketed by USV, the only antihypertensive agent sold by that company. These details provide a background.
AB - This communication is being started as I await a flight to New Orleans, where I am to give Medical Grand Rounds at the LSU Medical School later today. The expenses for my trip and an honorarium of $500 are being provided by the USV Pharmaceutical Company. These arrangements were made by the chairman of the department who wished to invite me. My talk, “Alpha- and Beta-Blockers in the Treatment of Hypertension,” will make only brief mention of diuretics and no reference to the diuretic marketed by USV, the only antihypertensive agent sold by that company. These details provide a background.
UR - http://www.scopus.com/inward/record.url?scp=0018347792&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018347792&partnerID=8YFLogxK
U2 - 10.1056/NEJM197901253000411
DO - 10.1056/NEJM197901253000411
M3 - Editorial
C2 - 759847
AN - SCOPUS:0018347792
SN - 0028-4793
VL - 300
SP - 194
EP - 196
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 4
ER -